Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $255
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Adam Maeder maintains an Overweight rating on Inspire Medical Systems (INSP) and raises the price target from $250 to $255.
May 08, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler maintains an Overweight rating on Inspire Medical Systems and raises the price target from $250 to $255.
The increase in price target by Piper Sandler suggests a positive outlook on Inspire Medical Systems' stock, likely due to anticipated performance improvements or market conditions favoring the company. This analyst action can positively influence investor sentiment and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100